Zobrazeno 1 - 10
of 37
pro vyhledávání: '"YASUKO MURAKAWA"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Patients presenting with inoperable colon cancer at first onset (ICF) or at time of relapse (ICR) are considered in unrecoverable. The therapeutic goal for unrecoverable cancer is to prolong overall survival (OS) and maintain a hi
Externí odkaz:
https://doaj.org/article/1f7f6e3ef7cd4e068b5a659d63549ddd
Publikováno v:
BMC Palliative Care, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background This study aimed to analyze the determinants of patients’ choice between palliative chemotherapy and best supportive care (BSC) and to investigate how this choice affects overall survival (OS) and length of hospitalization accor
Externí odkaz:
https://doaj.org/article/5c3bc26df47d4bd8aa0c60dd9a992e92
Autor:
Shin Takahashi, Kota Ouchi, Yasuhiro Sakamoto, Takahiro Mori, Hideki Shimodaira, Masahiro Takahashi, Hisatsugu Ohori, Chieko Kudo, Yoshikazu Takahashi, Hiroo Imai, Shoko Akiyama, Masanobu Takahashi, Takeshi Suto, Yasuko Murakawa, Takayuki Oishi, Hideki Isobe, Yoshinari Okada, Sadayuki Kawai, Takashi Yoshioka, Toshihiko Sato, Yoshiaki Shindo, Shunsuke Sugiyama, Keigo Komine, Natsuko Chiba, Akira Okita, Takuhiro Yamaguchi, Chikashi Ishioka
Publikováno v:
Journal of Gastrointestinal Oncology. 14:676-691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c29cda8e66f571638cf39d71e016f8
https://doi.org/10.21037/jgo-22-862
https://doi.org/10.21037/jgo-22-862
Publikováno v:
Journal of Pancreatic Cancer
Purpose: For incurable pancreatic cancer, the therapeutic goal is to prolong survival and maintain the quality of life (QOL). Unexpected outpatient consultation (OCT) and emergency hospitalization lead to QOL deterioration. The National Comprehensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e878ed731eb87d46bf2db63f42b85c
https://doi.org/10.1089/pancan.2021.0005
https://doi.org/10.1089/pancan.2021.0005
Autor:
Chikashi Ishioka, Kazunori Otsuka, Mariko Kanbe, Yoshiaki Shindo, Ken Saijo, Takashi Yoshioka, Masanobu Takahashi, Hideki Shimodaira, Takuhiro Yamaguchi, Yasuhiro Sakamoto, Kota Ouchi, Sadayuki Kawai, Hiroshi Honda, Yasuko Murakawa, Hidekazu Takahashi, Hisatsugu Ohori, Yuichi Tanaka
Publikováno v:
The Tohoku Journal of Experimental Medicine. 254:49-55
Whether trastuzumab use beyond disease progression is beneficial in second-line treatment for patients with unresectable human epidermal growth factor receptor 2 (HER2)-positive gastric cancer remains to be elucidated. We conducted this phase II stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55b8440c33ad90bf8280b3812524ef4
https://doi.org/10.1620/tjem.254.49
https://doi.org/10.1620/tjem.254.49
Autor:
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA, CHIKASHI ISHIOKA
Publikováno v:
Anticancer research. 42(4)
This phase II study assessed the efficacy of capecitabine plus cisplatin in patients with advanced gastric cancer refractory to adjuvant S-1.This single-arm, open-label, multicenter, phase II study was conducted by Tohoku Clinical Oncology Research a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d611359f1db4a9f2450e610bcac80f
https://pubmed.ncbi.nlm.nih.gov/35347022
https://pubmed.ncbi.nlm.nih.gov/35347022
Purpose: The therapeutic goal for advanced solid malignancies is not to achieve cure but to prolong survival and maintain quality of life (QOL). To date, no study has reported the trajectory of the QOL throughout the clinical course of a patient with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61418a4e813ceb300536d2470f7a8011
https://doi.org/10.21203/rs.2.20848/v1
https://doi.org/10.21203/rs.2.20848/v1
Publikováno v:
BMC Palliative Care
BMC Palliative Care, Vol 18, Iss 1, Pp 1-8 (2019)
BMC Palliative Care, Vol 18, Iss 1, Pp 1-8 (2019)
Background This study aimed to analyze the determinants of patients’ choice between palliative chemotherapy and best supportive care (BSC) and to investigate how this choice affects overall survival (OS) and length of hospitalization according to E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd02762e673f588d98cb93cddcc371c
https://pubmed.ncbi.nlm.nih.gov/31159782
https://pubmed.ncbi.nlm.nih.gov/31159782
Autor:
Masanobu Takahashi, Yasuko Murakawa, Takayuki Oishi, Akira Inoue, Chikashi Ishioka, Tatsuya Morita, Masanori Kawahara, Kazuki Sato, Jennifer W. Mack, Hideki Shimodaira, Mitsunori Miyashita, Shin Takahashi
Publikováno v:
Japanese journal of clinical oncology. 48(10)
Background Although reports have described the perceptions of curability among patients with unresectable/recurrent cancer and the quality of death and dying, the association between patients' perceptions and physicians' disclosures of incurability r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c186520f32e7563dc27feb3715c66a
https://pubmed.ncbi.nlm.nih.gov/30102399
https://pubmed.ncbi.nlm.nih.gov/30102399
Autor:
Masanobu Takahashi, Yasuhiro Sakamoto, Kazunori Otsuka, Mariko Kanbe, Hisatsugu Ohori, Yoshiaki Shindo, Hiroshi Honda, Ken Saijo, Kota Ouchi, Yasuko Murakawa, Hidekazu Takahashi, Sadayuki Kawai, Yuichi Tanaka, Takuhiro Yamaguchi, Hideki Shimodaira, Takashi Yoshioka, Chikashi Ishioka
Publikováno v:
Tohoku Journal of Experimental Medicine; May2021, Vol. 254 Issue 1, p49-55, 7p